4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-

Request For Quotation
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- Suppliers list
Company Name: Shanghai Xingui Biotechnology Co., Ltd.  
Tel: 15121041756
Email: xingui2022@126.com
Company Name: TargetMol  
Tel: 400-821-0310 15002144251
Email: xuexiang.shao@tsbiochem.com
Company Name: LGC Science (Shanghai) Ltd.  
Tel: 17717235263 17717235263
Email: offer.de@lgcgroup.com
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- Basic information
Product Name:4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
Synonyms:4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-;FBL-03G;5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one
CAS:199167-23-2
MF:C21H20O6
MW:368.38
EINECS:
Product Categories:
Mol File:199167-23-2.mol
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- Structure
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- Chemical Properties
Melting point 299 °C
Boiling point 605.5±55.0 °C(Predicted)
density 1.342±0.06 g/cm3(Predicted)
pka6.60±0.40(Predicted)
Safety Information
MSDS Information
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- Usage And Synthesis
UsesFBL-03G is used as a treatment for pancreatic cancer.
4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)- Preparation Products And Raw materials
Tag:4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-(199167-23-2) Related Product Information
SARS-CoV-2 3CLpro/3C-like protease protein SARS-COV-2 S protein RBD (194A.A, HEK293, HIS) SARS-COV-2 S protein RBD (HEK293, FC) SARS-COV-2 S protein RBD (N501Y, K417N, E484K, HEK293, HIS) SARS-CoV-2 S1 protein (HEK293) Ruxolitinib